https://www.selleckchem.com/pr....oducts/mitomycin-c.h
focused on off-label indications is needed to clarify whether they are effective, safe and cost-effective. © European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.OBJECTIVE The associated risk of vascular disease following diagnosis of type 2 diabetes in people previously identified as having pre-diabetes in real-world settings is unknown. We examined the presence of microvascular and macrovascular disease in individuals with newly diagnosed type 2 diabetes by glycemic
Gefällt mir
Kommentar
Teilen
